Kiora Pharmaceuticals, Inc. (KPRX)
NASDAQ: KPRX · Real-Time Price · USD
3.675
+0.065 (1.80%)
At close: Nov 4, 2024, 4:00 PM
3.580
-0.095 (-2.59%)
After-hours: Nov 4, 2024, 4:23 PM EST
Kiora Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Nov '24 Nov 4, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 11 | 4 | 6 | 19 | 27 | 41 | |
Market Cap Growth | 206.06% | -34.81% | -67.75% | -29.68% | -33.02% | 100.75% | |
Enterprise Value | -17 | -1 | 1 | 8 | 25 | 38 | |
Last Close Price | 3.67 | 4.70 | 30.87 | 543.60 | 1774.80 | 3607.20 | |
PE Ratio | 3.30 | -0.19 | -0.18 | -1.06 | -3.30 | - | |
PS Ratio | 0.49 | - | - | - | 2252.98 | 15.10 | |
PB Ratio | 0.33 | 0.66 | 0.54 | 1.31 | 2.79 | 6.13 | |
P/FCF Ratio | 2.30 | -0.42 | -0.59 | -1.78 | -3.70 | -4.97 | |
P/OCF Ratio | 2.28 | -0.42 | -0.59 | -1.79 | -3.71 | -4.97 | |
EV/Sales Ratio | -1.17 | - | - | - | 2038.07 | 14.23 | |
EV/EBITDA Ratio | -2.96 | 0.16 | -0.14 | -0.78 | -3.29 | -5.83 | |
EV/EBIT Ratio | -2.97 | 0.16 | -0.14 | -0.78 | -3.27 | -5.79 | |
EV/FCF Ratio | -3.95 | 0.14 | -0.14 | -0.77 | -3.35 | -4.69 | |
Debt / Equity Ratio | 0.00 | 0.02 | 0.01 | 0.01 | 0.06 | 0.01 | |
Debt / FCF Ratio | 0.02 | -0.01 | -0.01 | -0.02 | -0.08 | -0.01 | |
Asset Turnover | 0.53 | - | - | - | 0.00 | 0.22 | |
Quick Ratio | 19.02 | 2.76 | 2.24 | 5.21 | 0.64 | 2.67 | |
Current Ratio | 19.22 | 2.90 | 2.35 | 5.59 | 0.87 | 3.06 | |
Return on Equity (ROE) | 13.69% | -142.88% | -104.54% | -113.30% | -83.92% | -91.22% | |
Return on Assets (ROA) | 12.96% | -33.54% | -34.55% | -37.30% | -36.91% | -33.87% | |
Return on Capital (ROIC) | 16.78% | -61.27% | -50.98% | -52.67% | -55.15% | -52.80% | |
Earnings Yield | 24.45% | -311.53% | -220.45% | -72.08% | -25.26% | -17.50% | |
FCF Yield | 43.40% | -237.92% | -169.24% | -56.21% | -27.01% | -20.10% | |
Buyback Yield / Dilution | -1066.67% | -561.21% | -203.73% | -110.04% | - | - | |
Total Shareholder Return | -1066.67% | -561.21% | -203.73% | -110.04% | - | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.